Ingrid Vandenput

885 total citations
22 papers, 663 citations indexed

About

Ingrid Vandenput is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ingrid Vandenput has authored 22 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Obstetrics and Gynecology, 12 papers in Reproductive Medicine and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ingrid Vandenput's work include Endometrial and Cervical Cancer Treatments (20 papers), Uterine Myomas and Treatments (10 papers) and Ovarian cancer diagnosis and treatment (10 papers). Ingrid Vandenput is often cited by papers focused on Endometrial and Cervical Cancer Treatments (20 papers), Uterine Myomas and Treatments (10 papers) and Ovarian cancer diagnosis and treatment (10 papers). Ingrid Vandenput collaborates with scholars based in Belgium, Norway and Netherlands. Ingrid Vandenput's co-authors include Frédéric Amant, Ignace Vergote, Helga B. Salvesen, Jone Trovik, Janusz Marcickiewicz, Ingunn M. Stefansson, Lars A. Akslen, Elisabeth Wik, Solveig Tingulstad and Karin Leunen and has published in prestigious journals such as PLoS ONE, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

Ingrid Vandenput

22 papers receiving 650 citations

Peers

Ingrid Vandenput
Rebecca J. Wolsky United States
Ingrid Vandenput
Citations per year, relative to Ingrid Vandenput Ingrid Vandenput (= 1×) peers Rebecca J. Wolsky

Countries citing papers authored by Ingrid Vandenput

Since Specialization
Citations

This map shows the geographic impact of Ingrid Vandenput's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingrid Vandenput with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingrid Vandenput more than expected).

Fields of papers citing papers by Ingrid Vandenput

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingrid Vandenput. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingrid Vandenput. The network helps show where Ingrid Vandenput may publish in the future.

Co-authorship network of co-authors of Ingrid Vandenput

This figure shows the co-authorship network connecting the top 25 collaborators of Ingrid Vandenput. A scholar is included among the top collaborators of Ingrid Vandenput based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingrid Vandenput. Ingrid Vandenput is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lange, Norbert, Janice S. Kwon, Ingrid Vandenput, et al.. (2019). Neoadjuvant Chemotherapy Followed by Surgery for Advanced-Stage Endometrial Cancer. Current Oncology. 26(2). 226–232. 33 indexed citations
2.
Pijlman, Brenda, M. Caroline Vos, Monique J.M. de Groot, et al.. (2017). Opportunistic salpingectomy in women undergoing hysterectomy: Results from the HYSTUB randomised controlled trial. Maturitas. 107. 1–6. 24 indexed citations
3.
Visser, Nicole C.M., Johan Bulten, A.A.M. van der Wurff, et al.. (2015). PIpelle Prospective ENDOmetrial carcinoma (PIPENDO) study, pre-operative recognition of high risk endometrial carcinoma: a multicentre prospective cohort study. BMC Cancer. 15(1). 487–487. 14 indexed citations
4.
Heitz, Florian, Frédéric Amant, Christina Fotopoulou, et al.. (2013). Synchronous Ovarian and Endometrial Cancer— an International Multicenter Case-Control Study. International Journal of Gynecological Cancer. 24(1). 54–60. 42 indexed citations
5.
Trovik, Jone, Elisabeth Wik, Henrica M.J. Werner, et al.. (2013). Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial. European Journal of Cancer. 49(16). 3431–3441. 120 indexed citations
6.
Vandenput, Ingrid, Ignace Vergote, Patrick Neven, & Frédéric Amant. (2012). Weekly Paclitaxel-Carboplatin Regimen in Patients With Primary Advanced or Recurrent Endometrial Carcinoma. International Journal of Gynecological Cancer. 22(4). 617–622. 10 indexed citations
7.
Lambrechts, Diether, Lieve Coenegrachts, Ingrid Vandenput, et al.. (2012). High-throughput interrogation of PIK3CA, PTEN, KRAS, FBXW7 and TP53 mutations in primary endometrial carcinoma. Gynecologic Oncology. 128(2). 327–334. 63 indexed citations
8.
Wang, Yongyi, Ingrid Vandenput, Patricia C. Ewing, et al.. (2012). Progesterone Inhibits Epithelial-to-Mesenchymal Transition in Endometrial Cancer. PLoS ONE. 7(1). e30840–e30840. 60 indexed citations
9.
Vandenput, Ingrid, Maria Dêbiec‐Rychter, Godelieve Verbist, et al.. (2011). Kit Gene in Endometrial Carcinoma: An Immunohistochemical and Mutational Analysis. International Journal of Gynecological Cancer. 21(2). 203–205. 3 indexed citations
10.
Vandenput, Ingrid, Jone Trovik, Ignace Vergote, et al.. (2011). The Role of Adjuvant Chemotherapy in Surgical Stages I–II Serous and Clear Cell Carcinomas and Carcinosarcoma of the Endometrium: A Collaborative Study. International Journal of Gynecological Cancer. 21(2). 332–336. 17 indexed citations
11.
Vandenput, Ingrid, Jone Trovik, Karin Leunen, et al.. (2011). Evolution in Endometrial Cancer. International Journal of Gynecological Cancer. 21(2). 316–322. 23 indexed citations
12.
Vandenput, Ingrid, Lieve Coenegrachts, Godelieve Verbist, et al.. (2011). Expression of ERCC1, p53, and Class III A-Tubulin Do Not Reveal Chemoresistance in Endometrial Cancer. International Journal of Gynecological Cancer. 21(6). 1071–1077. 11 indexed citations
13.
Vandenput, Ingrid. (2011). Clinicopathologic study in uterine cancer.. PubMed. 3(3). 189–202. 1 indexed citations
14.
Boes, Anne‐Sophie, Thomas Tousseyn, Ingrid Vandenput, et al.. (2011). Pitfall in the diagnosis of endometrial cancer: case report of an endometrioid adenocarcinoma arising from uterine adenomyosis.. PubMed. 32(4). 431–4. 21 indexed citations
15.
Vandenput, Ingrid, Thomas Vanhove, Ben Van Calster, et al.. (2010). The Use of Lymph Vessel Markers to Predict Endometrial Cancer Outcome. International Journal of Gynecological Cancer. 20(3). 363–367. 11 indexed citations
16.
Vandenput, Ingrid, Ignace Vergote, Karin Leunen, et al.. (2009). Leuven Dose-Dense Paclitaxel/Carboplatin Regimen in Patients With Primary Advanced or Recurrent Endometrial Carcinoma. International Journal of Gynecological Cancer. 19(6). 1147–1151. 17 indexed citations
17.
Vandenput, Ingrid, Ben Van Calster, Karin Leunen, et al.. (2009). Neoadjuvant chemotherapy followed by interval debulking surgery in patients with serous endometrial cancer with transperitoneal spread (stage IV): a new preferred treatment?. British Journal of Cancer. 101(2). 244–249. 58 indexed citations
18.
Vandenput, Ingrid, Isabelle Vanden Bempt, Karin Leunen, et al.. (2008). Limited Clinical Benefit from Trastuzumab in Recurrent Endometrial Cancer. Gynecologic and Obstetric Investigation. 67(1). 46–48. 8 indexed citations
19.
Vandenput, Ingrid, Frédéric Amant, Patrick Neven, et al.. (2007). Effectiveness of weekly topotecan in patients with recurrent epithelial ovarian cancer. International Journal of Gynecological Cancer. 17(1). 83–87. 13 indexed citations
20.
Amant, Frédéric, Ingrid Vandenput, Toon Van Gorp, Ignace Vergote, & Ph. Moerman. (2006). Endometrial carcinosarcoma with osteoclast-like giant cells.. PubMed. 27(1). 92–4. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026